Status:

COMPLETED

3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)

Lead Sponsor:

Fondation Ophtalmologique Adolphe de Rothschild

Conditions:

Optic Neuritis

Multiple Sclerosis

Eligibility:

All Genders

18+ years

Brief Summary

3D FLAIR, 3D T1 FAT SAT, coronal T2 and coronal T1 dixon sequences were usually used to assess visual deficits in MRI. Optic nerve examination is preferably performed using a coronal T2 sequence in or...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Decrease in visual acuity explored in MRI between january 2018 and january 2020

Exclusion

  • Past history of episode of Optic neuritis

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2020

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT04792866

Start Date

January 1 2018

End Date

August 1 2020

Last Update

March 15 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Fondation Adolphe de Rothschild

Paris, Île-de-France Region, France, 75019

3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON) | DecenTrialz